155 related articles for article (PubMed ID: 20584580)
21. Salvage surgery after failed chemoradiotherapy in squamous cell carcinoma of the esophagus.
Chao YK; Chan SC; Chang HK; Liu YH; Wu YC; Hsieh MJ; Tseng CK; Liu HP
Eur J Surg Oncol; 2009 Mar; 35(3):289-94. PubMed ID: 18396384
[TBL] [Abstract][Full Text] [Related]
22. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
23. [Biomarkers of predicting response to neoadjuvant chemoradiotherapy in esophageal cancer].
Fu JH
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Sep; 16(9):805-10. PubMed ID: 24061981
[TBL] [Abstract][Full Text] [Related]
24. Pre-operative chemo-radiotherapy improves 3-year survival in people with resectable oesophageal cancer.
Naughton P; Walsh TN
Cancer Treat Rev; 2004 Feb; 30(1):141-4. PubMed ID: 14766133
[No Abstract] [Full Text] [Related]
25. [Chemoradiotherapy for esophageal cancer].
Fujita H; Sueyoshi S; Tanaka T; Sasahara H; Matono S; Yamana H; Shirouzu K; Suzuki G; Hayabuchi N
Gan To Kagaku Ryoho; 2003 Jul; 30(7):937-43. PubMed ID: 12894707
[TBL] [Abstract][Full Text] [Related]
26. Neoadjuvant chemoradiotherapy in esophageal cancer: is it still the question?
Pereira B; Gourgou-Bourgade S; Azria D; Ychou M
J Clin Oncol; 2008 Nov; 26(31):5133-4; author reply 5134. PubMed ID: 18838699
[No Abstract] [Full Text] [Related]
27. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
Choi N; Park SD; Lynch T; Wright C; Ancukiewicz M; Wain J; Donahue D; Mathisen D
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):111-22. PubMed ID: 15337546
[TBL] [Abstract][Full Text] [Related]
28. Multimodality treatment for esophageal cancer: the role of surgery and neoadjuvant therapy.
Makary MA; Kiernan PD; Sheridan MJ; Tonnesen G; Hetrick V; Vaughan B; Graling P; Elster E
Am Surg; 2003 Aug; 69(8):693-700; discussion 700-2. PubMed ID: 12953828
[TBL] [Abstract][Full Text] [Related]
29. [Long term results of esophageal epidermoid cancers in complete remission after preoperative chemo-radiotherapy].
Triboulet JP; Amrouni H; Guillem P; Vandenhaute B; Lecomte-Houcke M; Adenis A
Ann Chir; 1998; 52(6):503-8. PubMed ID: 9752498
[TBL] [Abstract][Full Text] [Related]
30. [Preoperative chemoradiation in esophageal cancer: experience of a single center in 102 patients].
Imdahl A; Schöffel U; Ruf G; Hopf UT
Zentralbl Chir; 2004 Oct; 129(5):350-5. PubMed ID: 15486784
[TBL] [Abstract][Full Text] [Related]
31. [Neoadjuvant treatment in surgery of esophageal cancer].
Launois B; Raoul JL; Leprise E; Meunier B
Bull Acad Natl Med; 2000; 184(8):1703-13; discussion 1714. PubMed ID: 11471389
[TBL] [Abstract][Full Text] [Related]
32. REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy.
Motoyama S; Sugiyama T; Ueno Y; Okamoto H; Takasawa S; Nanjo H; Watanabe H; Maruyama K; Okuyama M; Ogawa J
Ann Surg Oncol; 2006 Dec; 13(12):1724-31. PubMed ID: 17009160
[TBL] [Abstract][Full Text] [Related]
33. American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma.
Rizk NP; Venkatraman E; Bains MS; Park B; Flores R; Tang L; Ilson DH; Minsky BD; Rusch VW;
J Clin Oncol; 2007 Feb; 25(5):507-12. PubMed ID: 17290058
[TBL] [Abstract][Full Text] [Related]
34. Esophageal cancer surgery in 2005.
Wright CD
Minerva Chir; 2005 Dec; 60(6):431-44. PubMed ID: 16401998
[TBL] [Abstract][Full Text] [Related]
35. Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma.
Tachimori Y; Kanamori N; Uemura N; Hokamura N; Igaki H; Kato H
J Thorac Cardiovasc Surg; 2009 Jan; 137(1):49-54. PubMed ID: 19154902
[TBL] [Abstract][Full Text] [Related]
36. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation.
Gu Y; Swisher SG; Ajani JA; Correa AM; Hofstetter WL; Liao Z; Komaki RR; Rashid A; Hamilton SR; Wu TT
Cancer; 2006 Mar; 106(5):1017-25. PubMed ID: 16456809
[TBL] [Abstract][Full Text] [Related]
37. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
[TBL] [Abstract][Full Text] [Related]
38. Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response.
Rohatgi P; Swisher SG; Correa AM; Wu TT; Liao Z; Komaki R; Walsh GL; Vaporciyan AA; Rice DC; Roth JA; Ajani JA
Cancer; 2005 Dec; 104(11):2365-72. PubMed ID: 16245310
[TBL] [Abstract][Full Text] [Related]
39. Esophageal cancer: adjuvant therapy.
Ku GY; Ilson DH
Cancer J; 2007; 13(3):162-7. PubMed ID: 17620765
[TBL] [Abstract][Full Text] [Related]
40. Accuracy of pathologic examination in detection of complete response after chemoradiation for esophageal cancer.
Chang EY; Smith CA; Corless CL; Thomas CR; Hunter JG; Jobe BA
Am J Surg; 2007 May; 193(5):614-7; discussion 617. PubMed ID: 17434367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
